189 related articles for article (PubMed ID: 28614776)
1. Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gatric pentadecapeptide BPC 157 in rats.
Vitaic S; Stupnisek M; Drmic D; Bauk L; Kokot A; Klicek R; Vcev A; Luetic K; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2017 Apr; 68(2):265-272. PubMed ID: 28614776
[TBL] [Abstract][Full Text] [Related]
2. BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure.
Petrovic I; Dobric I; Drmic D; Sever M; Klicek R; Radic B; Brcic L; Kolenc D; Zlatar M; Kunjko K; Jurcic D; Martinac M; Rasic Z; Boban Blagaic A; Romic Z; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2011 Oct; 62(5):527-34. PubMed ID: 22204800
[TBL] [Abstract][Full Text] [Related]
3. Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157.
Dobric I; Drvis P; Petrovic I; Shejbal D; Brcic L; Blagaic AB; Batelja L; Sever M; Kokic N; Tonkic A; Zoricic I; Mise S; Staresinic M; Radic B; Jakir A; Babel J; Ilic S; Vuksic T; Jelic I; Anic T; Seiwerth S; Sikiric P
J Pharmacol Sci; 2007 May; 104(1):7-18. PubMed ID: 17452811
[TBL] [Abstract][Full Text] [Related]
4. An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157.
Petrovic I; Dobric I; Drvis P; Shejbal D; Brcic L; Blagaic AB; Batelja L; Kokic N; Tonkic A; Mise S; Baotic T; Staresinic M; Radic B; Jakir A; Vuksic T; Anic T; Seiwerth S; Sikiric P
J Pharmacol Sci; 2006 Nov; 102(3):269-77. PubMed ID: 17116974
[TBL] [Abstract][Full Text] [Related]
5. Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.
Cesarec V; Becejac T; Misic M; Djakovic Z; Olujic D; Drmic D; Brcic L; Rokotov DS; Seiwerth S; Sikiric P
Eur J Pharmacol; 2013 Feb; 701(1-3):203-12. PubMed ID: 23220707
[TBL] [Abstract][Full Text] [Related]
6. High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736).
Ilic S; Drmic D; Zarkovic K; Kolenc D; Coric M; Brcic L; Klicek R; Radic B; Sever M; Djuzel V; Ivica M; Boban Blagaic A; Zoricic Z; Anic T; Zoricic I; Djidic S; Romic Z; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2010 Apr; 61(2):241-50. PubMed ID: 20436226
[TBL] [Abstract][Full Text] [Related]
7. Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME.
Djakovic Z; Djakovic I; Cesarec V; Madzarac G; Becejac T; Zukanovic G; Drmic D; Batelja L; Zenko Sever A; Kolenc D; Pajtak A; Knez N; Japjec M; Luetic K; Stancic-Rokotov D; Seiwerth S; Sikiric P
World J Gastroenterol; 2016 Nov; 22(41):9127-9140. PubMed ID: 27895400
[TBL] [Abstract][Full Text] [Related]
8. Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions.
Ilic S; Drmic D; Franjic S; Kolenc D; Coric M; Brcic L; Klicek R; Radic B; Sever M; Djuzel V; Filipovic M; Djakovic Z; Stambolija V; Blagaic AB; Zoricic I; Gjurasin M; Stupnisek M; Romic Z; Zarkovic K; Dzidic S; Seiwerth S; Sikiric P
Life Sci; 2011 Mar; 88(11-12):535-42. PubMed ID: 21295044
[TBL] [Abstract][Full Text] [Related]
9. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.
Sikiric P; Seiwerth S; Rucman R; Turkovic B; Rokotov DS; Brcic L; Sever M; Klicek R; Radic B; Drmic D; Ilic S; Kolenc D; Vrcic H; Sebecic B
Curr Pharm Des; 2011; 17(16):1612-32. PubMed ID: 21548867
[TBL] [Abstract][Full Text] [Related]
10. Duodenocutaneous fistula in rats as a model for "wound healing-therapy" in ulcer healing: the effect of pentadecapeptide BPC 157, L-nitro-arginine methyl ester and L-arginine.
Skorjanec S; Kokot A; Drmic D; Radic B; Sever M; Klicek R; Kolenc D; Zenko A; Lovric Bencic M; Belosic Halle Z; Situm A; Zivanovic Posilovic G; Masnec S; Suran J; Aralica G; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2015 Aug; 66(4):581-90. PubMed ID: 26348082
[TBL] [Abstract][Full Text] [Related]
11. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157.
Sikiric P; Seiwerth S; Rucman R; Turkovic B; Rokotov DS; Brcic L; Sever M; Klicek R; Radic B; Drmic D; Ilic S; Kolenc D; Aralica G; Safic H; Suran J; Rak D; Dzidic S; Vrcic H; Sebecic B
Curr Pharm Des; 2013; 19(1):76-83. PubMed ID: 22950504
[TBL] [Abstract][Full Text] [Related]
12. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response.
Sikiric P; Seiwerth S; Brcic L; Blagaic AB; Zoricic I; Sever M; Klicek R; Radic B; Keller N; Sipos K; Jakir A; Udovicic M; Tonkic A; Kokic N; Turkovic B; Mise S; Anic T
Inflammopharmacology; 2006 Dec; 14(5-6):214-21. PubMed ID: 17186181
[TBL] [Abstract][Full Text] [Related]
13. Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157.
Barisic I; Balenovic D; Klicek R; Radic B; Nikitovic B; Drmic D; Udovicic M; Strinic D; Bardak D; Berkopic L; Djuzel V; Sever M; Cvjetko I; Romic Z; Sindic A; Bencic ML; Seiwerth S; Sikiric P
Regul Pept; 2013 Feb; 181():50-66. PubMed ID: 23327997
[TBL] [Abstract][Full Text] [Related]
14. Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats.
Sikiric P; Seiwerth S; Grabarevic Z; Rucman R; Petek M; Jagic V; Turkovic B; Rotkvic I; Mise S; Zoricic I; Konjevoda P; Perovic D; Simicevic V; Separovic J; Hanzevacki M; Ljubanovic D; Artukovic B; Bratulic M; Tisljar M; Rekic B; Gjurasin M; Miklic P; Buljat G
J Physiol Paris; 1997; 91(3-5):113-22. PubMed ID: 9403784
[TBL] [Abstract][Full Text] [Related]
15. Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.
Klicek R; Kolenc D; Suran J; Drmic D; Brcic L; Aralica G; Sever M; Holjevac J; Radic B; Turudic T; Kokot A; Patrlj L; Rucman R; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2013 Oct; 64(5):597-612. PubMed ID: 24304574
[TBL] [Abstract][Full Text] [Related]
16. Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats.
Ilic S; Drmic D; Zarkovic K; Kolenc D; Brcic L; Radic B; Djuzel V; Blagaic AB; Romic Z; Dzidic S; Kalogjera L; Seiwerth S; Sikiric P
Eur J Pharmacol; 2011 Sep; 667(1-3):322-9. PubMed ID: 21645505
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME.
Drmic D; Kolenc D; Ilic S; Bauk L; Sever M; Zenko Sever A; Luetic K; Suran J; Seiwerth S; Sikiric P
World J Gastroenterol; 2017 Aug; 23(29):5304-5312. PubMed ID: 28839430
[TBL] [Abstract][Full Text] [Related]
18. An endogeous defensive concept, renewed cytoprotection/adaptive cytoprotection: intra(per)-oral/intragastric strong alcohol in rat. Involvement of pentadecapeptide BPC 157 and nitric oxide system.
Becejac T; Cesarec V; Drmic D; Hirsl D; Madzarac G; Djakovic Z; Bunjevac I; A Zenko Sever A; Sepac A; Batelja Vuletic L; Stancic Rokotov D; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279308
[TBL] [Abstract][Full Text] [Related]
19. Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.
Boban Blagaic A; Blagaic V; Mirt M; Jelovac N; Dodig G; Rucman R; Petek M; Turkovic B; Anic T; Dubovecak M; Staresinic M; Seiwerth S; Sikiric P
Eur J Pharmacol; 2005 Apr; 512(2-3):173-9. PubMed ID: 15840402
[TBL] [Abstract][Full Text] [Related]
20. Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula.
Grgic T; Grgic D; Drmic D; Sever AZ; Petrovic I; Sucic M; Kokot A; Klicek R; Sever M; Seiwerth S; Sikiric P
Eur J Pharmacol; 2016 Jun; 780():1-7. PubMed ID: 26875638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
